|
|
|
Volumn 51, Issue 10, 2002, Pages 821-
|
|
Do the risks of estrogen plus progestin outweigh the benefits in healthy postmenopausal women?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM;
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
PLACEBO;
VITAMIN D;
ACUTE HEART INFARCTION;
ADULT;
AGED;
BREAST CARCINOMA;
CALCULATION;
CANCER INVASION;
CANCER RISK;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COLORECTAL CARCINOMA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES MELLITUS;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
ELECTROCARDIOGRAM;
FEMALE;
FOLLOW UP;
HEART DEATH;
HIP FRACTURE;
HORMONE SUBSTITUTION;
HOSPITALIZATION;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
LOW FAT DIET;
MAJOR CLINICAL STUDY;
MORTALITY;
PATIENT SELECTION;
POSTMENOPAUSE;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
SIDE EFFECT;
STROKE;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
VITAMIN SUPPLEMENTATION;
|
|
EID: 0036791786
PISSN: 00943509
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
